Skip to content
The Mumbai

Alivus Life Sciences Posts Strong Q2 FY27 Results, Revenue Grows 16% YoY, PAT Jumps 51.3%

Alivus Life Sciences Posts Strong Q2 FY27 Results, Revenue Grows 16% YoY, PAT Jumps 51.3%
Photo: Free Press Journal · view original

Mumbai: Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, announced its financial results for the second quarter and half-year ended September 30, 2026, on October 29, 2026. Financial Highlights Revenue from operations for Q2 FY27 stood at ₹682 crore, growing 16.0% YoY. The n...

Sources and story details